1[1]Dandona P,Nix D, Wilson MF,et al.Procalcitonin increase after en-dotoxin injection in normal subjects.J Chin Endocrinol Metab, 1994,79:1605-1608.
2[2]Oberhoffer M,Stonans I,Russwurm S, et al.Procalcitonin expression in human peripheral blood mononuclear cells and its mudalution by lipopolysaccharides and sepsis related cytokines in vitro.J Lab Clin Med, 1999,134:49-55.
3[3]Nylen ES,Whang KT,Snider TH,et al.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.Crit Care Med, 1998,26(6):1001-1006.
4[4]Whang KT,Vath SD,Becker KL, et al.Procalcitonin and proin-flammatory cytokine interactions in sepsis.Shock,2000,14(1):73-78.
6[6]Oberhoffer M,Vogelsang H,Russwurm S, et al.Outcome prediction by tra-ditional and new markers of inflammation in patients with sepsis.Clin Chem Lab Med,1999,37(3):363-368.
7[7]Brunkhorst F M,Wegschider Z,Forycki ZF,et al.Procalcitonin for early diagnosis and differentiation of SIRS,sepsis ,severe sepsis ,and septic shock.Intensive Care Medicine,2000,26:148-152.
8[8]Zeni F,Viallon A,Assicot M,et al.Procalcitonin serum concentrations and severity of sepsis. Clin Inters Care,1994,5:(suppl2):89-98.
9[9]Anonymous.American college of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis .Crit Care Med,1992,20:864-874.
10[10]Bone RC.Definition for sepsis and organ failure.Crit Care Med, 1992,19:973-976.
